Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16093989rdf:typepubmed:Citationlld:pubmed
pubmed-article:16093989lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16093989lifeskim:mentionsumls-concept:C1184738lld:lifeskim
pubmed-article:16093989lifeskim:mentionsumls-concept:C0153601lld:lifeskim
pubmed-article:16093989lifeskim:mentionsumls-concept:C0332305lld:lifeskim
pubmed-article:16093989lifeskim:mentionsumls-concept:C0024485lld:lifeskim
pubmed-article:16093989lifeskim:mentionsumls-concept:C1450054lld:lifeskim
pubmed-article:16093989lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:16093989lifeskim:mentionsumls-concept:C0386370lld:lifeskim
pubmed-article:16093989pubmed:issue3lld:pubmed
pubmed-article:16093989pubmed:dateCreated2005-8-11lld:pubmed
pubmed-article:16093989pubmed:abstractTextWe evaluated lymphotropic nanoparticle enhanced magnetic resonance imaging (LNMRI) with ferumoxtran-10 in determining the presence of regional lymph node metastases in patients with penile cancer.lld:pubmed
pubmed-article:16093989pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16093989pubmed:languageenglld:pubmed
pubmed-article:16093989pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16093989pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16093989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16093989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16093989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16093989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16093989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16093989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16093989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16093989pubmed:statusMEDLINElld:pubmed
pubmed-article:16093989pubmed:monthSeplld:pubmed
pubmed-article:16093989pubmed:issn0022-5347lld:pubmed
pubmed-article:16093989pubmed:authorpubmed-author:HarisinghaniM...lld:pubmed
pubmed-article:16093989pubmed:authorpubmed-author:McDougalW...lld:pubmed
pubmed-article:16093989pubmed:authorpubmed-author:TabatabaeiSha...lld:pubmed
pubmed-article:16093989pubmed:issnTypePrintlld:pubmed
pubmed-article:16093989pubmed:volume174lld:pubmed
pubmed-article:16093989pubmed:ownerNLMlld:pubmed
pubmed-article:16093989pubmed:authorsCompleteYlld:pubmed
pubmed-article:16093989pubmed:pagination923-7; discussion 927lld:pubmed
pubmed-article:16093989pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:meshHeadingpubmed-meshheading:16093989...lld:pubmed
pubmed-article:16093989pubmed:year2005lld:pubmed
pubmed-article:16093989pubmed:articleTitleRegional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.lld:pubmed
pubmed-article:16093989pubmed:affiliationDepartment of Urology, The Massachusetts General Hospital and The Harvard Medical School, Boston, Massachusetts 02114, USA.lld:pubmed
pubmed-article:16093989pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16093989lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16093989lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16093989lld:pubmed